BioCentury | Feb 1, 2016
Clinical News

Illumigene Malaria regulatory update

Meridian received CE Mark approval for its illumigene Malaria test to detect malaria. The molecular test uses loop-mediated isothermal amplification (LAMP) technology to amplify DNA and detect the presence of malaria DNA and provides results...
BioCentury | Aug 17, 2015
Clinical News

Illumigene HSV 1&2 molecular assay regulatory update

FDA granted 510(k) clearance to Meridian’s illumigene HSV 1&2 molecular assay to detect herpes simplex virus type 1 (HSV-1) and HSV-2. The company said the assay is immediately available in the U.S. Earlier this year,...
BioCentury | Jul 13, 2015
Company News

Meridian Bioscience sales and marketing update

Meridian received CE Mark approval and launched its molecular assays in the EU to detect herpes simplex virus type 1 (HSV-1) and HSV-2. The assays run on the company’s illumigene technology and use loop-mediated isothermal...
BioCentury | Apr 13, 2015
Clinical News

Illumigene Gonorrhea regulatory update

Meridian Bioscience received CE Mark approval for its illumigene Chlamydia test to detect Chlamydia trachomatis and Illumigene Gonorrhea test to detect Neisseria gonorrhoeae. illumigene is a molecular-based platform based on DNA amplification utilizing loop amplification...
BioCentury | Apr 13, 2015
Clinical News

Illumigene Chlamydia regulatory update

Meridian Bioscience received CE Mark approval for its illumigene Chlamydia test to detect Chlamydia trachomatis and Illumigene Gonorrhea test to detect Neisseria gonorrhoeae. illumigene is a molecular-based platform based on DNA amplification utilizing loop amplification...
BioCentury | Oct 23, 2014
Cover Story

Diagnosing resistance

It might be a day late and a dollar short, but the U.S. government is finally getting around to addressing what many experts think is the big unserved need in antibiotic resistance-new diagnostics. Faster, more...
BioCentury | Jun 9, 2014
Clinical News

Illumigene Mycoplasma regulatory update

Meridian said Health Canada approved Meridian's illumigene Mycoplasma test to detect Mycoplasma pneumonia and illumigene Pertussis test to detect Bordetella pertussis. Meridian said the test is now available in the country. The in vitro molecular...
BioCentury | Jun 9, 2014
Clinical News

Illumigene Pertussis regulatory update

Meridian said Health Canada approved Meridian's illumigene Mycoplasma test to detect Mycoplasma pneumonia and illumigene Pertussis test to detect Bordetella pertussis. Merdian said the test is now available in the country. The in vitro molecular...
BioCentury | Apr 7, 2014
Clinical News

Illumigene Pertussis regulatory update

FDA granted 510(k) clearance for Meridian's illumigene Pertussis test to detect Bordetella pertussis. The company plans to launch the product in the U.S. in the next month. The in vitro molecular diagnostic uses DNA amplification...
BioCentury | Jun 24, 2013
Clinical News

Illumigene Mycoplasma regulatory update

FDA approved Meridian's illumigene Mycoplasma test to detect Mycoplasma pneumoniae. The company plans to launch the product in the U.S. by the end of this month. The in vitro molecular diagnostic uses isothermal DNA amplification...
Items per page:
1 - 10 of 22
BioCentury | Feb 1, 2016
Clinical News

Illumigene Malaria regulatory update

Meridian received CE Mark approval for its illumigene Malaria test to detect malaria. The molecular test uses loop-mediated isothermal amplification (LAMP) technology to amplify DNA and detect the presence of malaria DNA and provides results...
BioCentury | Aug 17, 2015
Clinical News

Illumigene HSV 1&2 molecular assay regulatory update

FDA granted 510(k) clearance to Meridian’s illumigene HSV 1&2 molecular assay to detect herpes simplex virus type 1 (HSV-1) and HSV-2. The company said the assay is immediately available in the U.S. Earlier this year,...
BioCentury | Jul 13, 2015
Company News

Meridian Bioscience sales and marketing update

Meridian received CE Mark approval and launched its molecular assays in the EU to detect herpes simplex virus type 1 (HSV-1) and HSV-2. The assays run on the company’s illumigene technology and use loop-mediated isothermal...
BioCentury | Apr 13, 2015
Clinical News

Illumigene Gonorrhea regulatory update

Meridian Bioscience received CE Mark approval for its illumigene Chlamydia test to detect Chlamydia trachomatis and Illumigene Gonorrhea test to detect Neisseria gonorrhoeae. illumigene is a molecular-based platform based on DNA amplification utilizing loop amplification...
BioCentury | Apr 13, 2015
Clinical News

Illumigene Chlamydia regulatory update

Meridian Bioscience received CE Mark approval for its illumigene Chlamydia test to detect Chlamydia trachomatis and Illumigene Gonorrhea test to detect Neisseria gonorrhoeae. illumigene is a molecular-based platform based on DNA amplification utilizing loop amplification...
BioCentury | Oct 23, 2014
Cover Story

Diagnosing resistance

It might be a day late and a dollar short, but the U.S. government is finally getting around to addressing what many experts think is the big unserved need in antibiotic resistance-new diagnostics. Faster, more...
BioCentury | Jun 9, 2014
Clinical News

Illumigene Mycoplasma regulatory update

Meridian said Health Canada approved Meridian's illumigene Mycoplasma test to detect Mycoplasma pneumonia and illumigene Pertussis test to detect Bordetella pertussis. Meridian said the test is now available in the country. The in vitro molecular...
BioCentury | Jun 9, 2014
Clinical News

Illumigene Pertussis regulatory update

Meridian said Health Canada approved Meridian's illumigene Mycoplasma test to detect Mycoplasma pneumonia and illumigene Pertussis test to detect Bordetella pertussis. Merdian said the test is now available in the country. The in vitro molecular...
BioCentury | Apr 7, 2014
Clinical News

Illumigene Pertussis regulatory update

FDA granted 510(k) clearance for Meridian's illumigene Pertussis test to detect Bordetella pertussis. The company plans to launch the product in the U.S. in the next month. The in vitro molecular diagnostic uses DNA amplification...
BioCentury | Jun 24, 2013
Clinical News

Illumigene Mycoplasma regulatory update

FDA approved Meridian's illumigene Mycoplasma test to detect Mycoplasma pneumoniae. The company plans to launch the product in the U.S. by the end of this month. The in vitro molecular diagnostic uses isothermal DNA amplification...
Items per page:
1 - 10 of 22